Fortitude Family Office’s Tyra Biosciences TYRA Stock Holding History

Fortitude Family Office’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$543	Buy	+17	New	+$562	﹤0.01%	1957

Other funds holding TYRA

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Fortitude Family Office's TYRA Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Tyra Biosciences (TYRA) in Q2 2026: 17 shares worth $543. The stake represents ﹤0.01% of the portfolio and ranks #1957 among its holdings.

16 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

Fortitude Family Office held 17 shares of Tyra Biosciences worth $543 as of Q2 2026.
Tyra Biosciences was a new Fortitude Family Office position in Q2 2026.
Tyra Biosciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1957 holding.
16 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.